Low-magnesium induces senescent features in cultured human endothelial cells

Silvia Ferrè1, Andrzej Mazur, Jeanette A M Maier

  • 1University of Milan, Department of Preclinical Sciences-LITA Vialba, Milano, Italy.

Magnesium Research
|June 1, 2007
PubMed

Insights

Low magnesium deficiency promotes endothelial senescence by increasing interleukin-1 alpha. This finding may explain how magnesium impacts cardiovascular diseases like atherosclerosis.

Area of Science:

  • Endothelial biology
  • Cardiovascular disease research
  • Molecular mechanisms of aging

Background:

  • Low magnesium (Mg) is linked to endothelial dysfunction and cardiovascular diseases.
  • Endothelial senescence is a contributing factor to atherosclerosis development.

Purpose of the Study:

  • To investigate the molecular mechanisms by which Mg deficiency affects endothelial cells.
  • To determine if Mg deficiency induces endothelial senescence and its role in cardiovascular disease.

Main Methods:

  • Cultured human endothelial cells were subjected to Mg deficiency.
  • Interleukin-1 alpha (IL-1α) levels and monocytoid cell adhesion were measured.
  • Expression of cell division cycle kinase (cdk) inhibitor p21 and senescence markers were assessed.
  • Proteasome activity was analyzed under Mg deficiency.

Main Results:

  • Mg deficiency induced pro-inflammatory interleukin-1 alpha (IL-1α) in endothelial cells.
  • Inhibition of IL-1α prevented low Mg-induced monocytoid cell adhesion and p21 upregulation.
  • Mg deficiency promoted features of endothelial senescence.
  • Mg deficiency affected gene expression and modulated proteasome activity.

Conclusions:

  • Mg deficiency promotes endothelial senescence via IL-1α induction.
  • This senescence contributes to the molecular link between Mg deficiency and cardiovascular diseases like atherosclerosis.
  • Understanding these mechanisms could inform strategies for preventing or treating Mg-related cardiovascular conditions.

Related Concept Videos